| Application no. and date | 06837238.2 (espacenet) (Federated) (European Patent Register), 20061107 | | Patent/reg. no. and date | DK/EP 1948608, 20120314 | | Publication date | 20080730 | | Priority no. and date | US 735224 P, 20051108 | | EP pub. no. and date |
EP 1948608 20080730 | | Effective date | | | Applicant/owner | MILLENNIUM PHARMACEUTICALS, INC., 40 Landsdowne Street
Cambridge, MA 02139, US | | Applicant ref. no. | PORT EP1948608 | | Inventor | GRANT, Craig, 10 Burgley Rise
Burwell CB5 0LW, GB,
KANTER, James P., 9591 Alcosta Blvd.
San Ramon, CA 94583, US,
LANGLANDS, Graeme, 44 Northfield Park
Soham, Cambs CB7 5UZ, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07D 213/75 (2006.01) | | Title | Farmaceutiske salte og polymorfe former af N-(5-chlor-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]-benzoyl]amino]-5-methoxybenzamid, en faktor xa-inhibitor | | Int. application no. | US2006043635 | | Int. publication no. | WO2007056517 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
